LARIGLIP-50 / LARGLIP-M

bt_bb_section_bottom_section_coverage_image

Lariglip 50

https://www.larivinpharma.com/wp-content/uploads/2023/06/Lariglip-50-tab.jpg

Composition

Lariglip-50

  • Active Ingredient: Vildagliptin 50mg
  • Indication: Used to improve blood sugar control in adults with type 2 diabetes mellitus.
  • Dosage:
    • Typical: 1 to 2 tablets per day, taken in divided doses.
    • Adjustments: Your doctor may adjust the dosage based on your blood sugar levels and individual needs.
  • Available Form: Tablets
  • Pack: 10 x 15 tablets/strip
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
https://www.larivinpharma.com/wp-content/uploads/2023/06/Lariglip-50-tab.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2023/06/Lariglip-M-tab.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png

Lariglip M

https://www.larivinpharma.com/wp-content/uploads/2023/06/Lariglip-M-tab.jpg

Composition

Lariglip M

  • Active Ingredients: Vildagliptin 50mg + Metformin 500mg
  • Indication: Used to improve blood sugar control in adults with type 2 diabetes mellitus, especially those who do not achieve adequate control with metformin alone.
  • Dosage:
    • Typical: 1 to 2 tablets per day, taken in divided doses.
    • Adjustments: Your doctor may adjust the dosage based on your blood sugar levels and individual needs.
  • Available Form: Tablets
  • Pack: 10 x 15 tablets/strip
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png

Key Differences Between Lariglip and Lariglip M

Feature Lariglip Lariglip M
Active Ingredients Vildagliptin 50mg Vildagliptin 50mg + Metformin 500mg
Use For patients with type 2 diabetes For patients with type 2 diabetes who need additional blood sugar control
Mechanism of Action Works by increasing the body’s ability to produce insulin Works by both increasing insulin production and decreasing glucose absorption

Export to Sheets

Adverse Effects (AEs)

  • Common:
    • Headache
    • Upper respiratory tract infection
    • Nasopharyngitis
    • Fatigue
    • Diarrhea
  • Less Common:
    • Abdominal pain
    • Nausea
    • Vomiting
    • Flatulence
    • Joint pain
    • Myalgia
    • Rash
    • Urinary tract infection
    • Dizziness
    • Back pain
    • Chest pain

Please note: This is not an exhaustive list of possible side effects. Inform your doctor immediately if you experience any unusual or concerning symptoms.

Precautions

  • Hypersensitivity: Do not use Lariglip or Lariglip M if you are allergic to any of the ingredients.
  • Kidney Problems: Use with caution in patients with impaired kidney function. Your doctor may need to adjust the dosage.
  • Liver Problems: Use with caution in patients with impaired liver function. Your doctor may need to adjust the dosage.
  • Pregnancy and Breastfeeding: Discuss the risks and benefits with your doctor if you are pregnant or breastfeeding.
  • Alcohol: Avoid excessive alcohol consumption while taking Lariglip or Lariglip M.
  • Hypoglycemia: Monitor your blood sugar levels closely, especially if you are also taking other medications that can lower blood sugar.

Remember: It’s essential to consult your healthcare provider for personalized advice and to ensure the safe and effective use of Lariglip or Lariglip M

Disclaimer:
This information is provided for educational purposes only. For personalized medical advice and treatment options, consult a healthcare professional.

https://www.larivinpharma.com/wp-content/uploads/2020/03/blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved